Michael Wang

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Michael Wang
Aug 14, 2024, 14:08 | Insight
Michael Wang: Phenotype- and target-driven discovery are necessary for finding cures
Michael Wang shared on X a recent paper by Zhenyi Wang et al. titled "Innovating…
Aug 12, 2024, 01:20 | Blog
Using CRISPR technology to enhance CAR-T cells
Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…
Jul 21, 2024, 12:19 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…
Jul 17, 2024, 05:10 | Insight
The ideal combination partner for BiTE therapy
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jul 13, 2024, 21:06 | Insight
Michael Wang: CDK9 is a promising target in MCL
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:17 | Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 | Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 19, 2024, 22:16 | Blog
Michael Wang: An international randomized phase 3 trial is a huge undertaking
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jun 17, 2024, 17:03 | Blog
Michael Wang: I presented the data from ECHO trial
Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…
May 21, 2024, 12:00 | Blog
Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Apr 15, 2024, 16:12 | Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Mar 31, 2024, 23:07 | Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
All: 13 Posts: 1 - 100
Special Coverage